Real-life studies in allergen immunotherapy

被引:12
|
作者
Passalacqua, Giovanni [1 ]
Bagnasco, Diego [1 ]
机构
[1] Univ Genoa, Allergy & Resp Dis, IRCCS Policlin San Martino, Lgo R Benzi 10, I-16133 Genoa, Italy
关键词
allergen immunotherapy; efficacy; real life; real world; safety; RANDOMIZED CONTROLLED-TRIALS; ADVERSE SYSTEMIC REACTIONS; SUBLINGUAL IMMUNOTHERAPY; EUROPEAN SURVEY; ASTHMA; RHINITIS; SAFETY; MANAGEMENT; EFFICACY; EASSI;
D O I
10.1097/ACI.0000000000000757
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review Real-life (or real-world) studies can provide information that cannot be derived from randomized controlled trials. This approach is currently becoming of relevance for many treatments. In recent years, the real-life method has been applied also to allergen immunotherapy, providing new insights on it. We reviewed herein the available literature on the argument. Recent findings Several prospective and retrospective studies on allergen immunotherapy in the real-world setting have been published, mostly in the last 5 years. Most of them focused on adverse events, compliance, and the long term/preventive effects, and evidenced an overall favorable profile for different products and different allergens. Real life study provided novel information and evidenced those aspects of immunotherapy that worth a more detailed approach, without the strict limitations usually imposed by controlled randomized trials.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 50 条
  • [31] Moving forward with allergen immunotherapy: The significance of real-world studies
    van Wijk, Roy Gerth
    van Daele, Paul
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 152 (02) : 362 - 364
  • [32] Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study
    Zidarn, M.
    Kosnik, M.
    Silar, M.
    Bajrovic, N.
    Korosec, P.
    ALLERGY, 2015, 70 (05) : 547 - 555
  • [33] Adherence to hymenoptera venom immunotherapy: Real-life data from Austria
    Fragner, M.
    Moser, J.
    Trautinger, F.
    Hafner, C.
    ALLERGY, 2020, 75 : 33 - 33
  • [34] Durable response after immunotherapy discontinuation: a multicenter real-life experience
    Bassanelli, Maria
    Giannarelli, Diana
    Russano, Marco
    Cecere, Fabiana Letizia
    Migliorino, Maria Rita
    Giacinti, Silvana
    Barucca, Viola
    Bria, Emilio
    Ruggeri, Enzo Maria
    Calabro, Fabio
    Gelibter, Alain
    Santini, Daniele
    Ceribelli, Anna
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [35] Risk factors and strategies in nonadherence with subcutaneous immunotherapy: a real-life study
    Yang, Yongshi
    Wang, Yin
    Yang, Lin
    Wang, Jingru
    Huang, Nan
    Wang, Xiaolong
    Hu, Lintao
    Jiang, Qing
    Liu, Guanghui
    Zhu, Rongfei
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2018, 8 (11) : 1267 - 1273
  • [36] Immunotherapy for malignant pleural mesothelioma: A French retrospective real-life study
    Crepin, F.
    Assie, J-B.
    Gauvain, C.
    Bonnefoy, V.
    Cortot, A. B.
    Chouaid, C.
    Scherpereel, A.
    Monnet, I.
    ANNALS OF ONCOLOGY, 2020, 31 : S1079 - S1080
  • [37] The MaDo real-life study of dose adjustment of allergen immunotherapy liquid formulations in an indication of respiratory allergic disease: Reasons, practices, and outcomes
    Thetis-Soulie, Marguerite
    Hosotte, Maxime
    Grozelier, Isabelle
    Baillez, Claire
    Scurati, Silvia
    Mercier, Valerie
    FRONTIERS IN ALLERGY, 2022, 3
  • [38] Real-life clinical practice studies in multiple sclerosis
    Costa-Frossard, Lucienne
    FARMACIA HOSPITALARIA, 2021, 45 (02) : 51 - 52
  • [39] Safety and Efficacy of Allergen Immunotherapy in the Treatment of Allergic Rhinitis and Asthma in Real Life
    Zeldin, Yuri
    Weiler, Zeev
    Magen, Eli
    Tiosano, Liran
    Kidon, Mona I.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (12): : 869 - 872
  • [40] Full symptom control in patients with allergic rhinoconjunctivitis induced by birch pollen treated with sublingual allergen immunotherapy (AIT) in real-life medical practice
    Hadler, M.
    Karagiannis, E.
    Shah-Hosseini, K.
    Moesges, R.
    ALLERGY, 2014, 69 : 509 - 509